Some monoclonal antibodies (MoAbs) directed against blood group M-related epitope of glycophorin A (GPA) were found t o agglutinate rare variant erythrocytes carrying GPA of Mg type. In contradistinction t o normal GPA-M or -N. the N-terminal portion of GPA-Mg is not glycosylated. Therefore, the multipin peptide synthesis was used for testing the specificity of the cross-reacting MoAbs. Among several anti-M and anti-N MoAbs tested, only three anti-M (E3, E6,425/28) agglutinated Mg erythrocytes and showed binding to the synthetic octapeptides corresponding t o N-terminal sequences of GPA-M (SSlTGVAM), GPA-N (LSlTEVAM), and GPA-Mg (LSTNEVAM). Testing multiple peptide analogs (window and replacement analysis) showed that these MoAbs were specific for peptidic epitope in which Met8 and Val6 were the most essential amino acid residues. The amino acid replacements Serl Leu1 or Gly5 ++ Glu5 (M Y N) and Thr4
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Asn4 (M and N Y Mg) had no or negligible effect on the reaction of synthetic peptides with the MoAbs. However, when Ser2, Thr3, and Thr4 carry 0-linked sialooli-HE MAJOR sialoglycoprotein of human erythrocyte membranes, glycophorin A (GPA), exists in two common forms differing in amino acid residues 1 and 5 that give rise to M and N blood groups."3 Many rare glycophorin variants were found, and those with amino acid replacements in N-terminal portion have abolished or modified blood group M or N activity. One of such variants is GPA of Mg type. The N-terminal portions of normal GPA-M and -N and GPA-ME have the following structures: M: Ser-Ser*-Thr*-Thr*-Gly-Val-Ala-Met-His-; N: Leu-Ser*-Thr*-Thr*-GluVal-Ala-Met-His-; Mg: Leu-Ser-Thr-Asn-Glu-Val-AlaMet-His-. In normal GPA Ser2, Thr3 and Thr4 (marked by asterisks) carry 0-linked oligosaccharide chains NeuAca2-3Gal~l-3[NeuAca2-6]GalNAc-. In GPA-Mg replacement of Thr4 by Asn results in lack of glycosylation of Ser2 and Thr3.4-h The incidence of ME antigen is extremely low (less than 0.01%), but anti-Mg antibodies are quite common in normal individuals, and they can be produced by immunization.' It has been accepted that polyclonal anti-M and anti-N sera do not react with M' antigen, which was not surprising, because these antibodies are specific for epitopes dependent on glycosylation.
gosaccharides (normal GPA-M or -NI, the MoAbs recognize Gly5-and sialic acid-dependent blood group M-related epitope. An interesting finding concerning anti-M/Mg MoAbs described here is the fact that glycosylation of amino acid residues adjacent to the most important part of peptidic epitope not only differentially modulates the proper exposure of peptidic epitope, but also alters the requirement for some amino acid residues present within the epitope. Pathologic conditions, including hematologic disorders, are often accompanied by alterations in protein glycosylation, resulting not only from differences in the structure of antigen polypeptide chain, but also from changes in specificity or expression of enzymes involved in glycosylation. Our present findings draw attention t o possibility of the bidirectional modulation of protein antigenicity by glycosylation and may be helpful in interpretation of some results obtained with MoAb used for diagnostic or other purposes. 0 1994 by The American Society of Hematology.
In view of these data, the reports on agglutination of Mg erythrocytes (MgN or MgMg) by some anti-M monoclonal antibodies (MoAbs) were quite intriguing.'"" The question arose why these MoAbs, which do not react or react weakly with GPA-N and asialoGPA-M and -N, show reaction with Mg antigen comparable with the reaction with sialylated M, despite the facts that ME antigen is not glycosylated and its amino acid sequence is more similar to that of N than M antigen.
The reactivity of anti"/Mg MoAbs with nonglycosylated peptidic epitope of Mg antigen prompted us to use multipin peptide synthesis to study their specificity. The results presented in this report showed that these MoAbs are specific for peptidic epitope independent of blood group-typical amino acid residues and that glycosylation of amino acid residues adjacent to the most important ones has profound effects on the epitope activity and specificity.
MATERIALS AND METHODS

Monoclonal antibodies (MoAbs).
The anti-M MoAbs 42Sl2B and E3 (both IgG), the MoAb 22. 19 For personal use only. on August 30, 2017. by guest www.bloodjournal.org From in phosphate-buffered saline was used. The neuraminidase-treated cells were washed with 0.1 molL citratelphosphate buffer. pH 6.0, containing 0.01% bovine serum albumin and 0.02% NaN3. The dense RBC suspension (150 pL) was treated with 2.5 mU (in 9 pL) of endo-a-N-acetylgalactosaminidase (0-glycanase; Oxford Glycosystems. Abingdon, UK). and the sample was incubated for 2 hours at 37°C and for 6 hours at 20°C and was left overnight in refrigerator. The control sample of asialo RBC was incubated under the same conditions. but the 0-glycanase was omitted. The cells were washed and used the next day.
Untreated, desialylated and deglycosylated RBC were used for hemagglutination assay performed in U-well microtiter plates, as described earlier. ' ' G/ycophorins. GPA from blood group OM and ON erythrocytes (GPA-M and GPA-N, respectively) and its modification products were obtained according to the previously described procedures."."
Immunohlotting Sodium dodecyl sulfate (SDS)-solubilized membrane proteins of blood group M, N. and MgN erythrocytes were fractionated by SDS-polyacrylamide gel electrophoresis (PAGE) in 10% gel" and transferred to nitrocellulose BA85 (Schleicher & Schuell, Dassel, Germany). Binding of the MoAbs to GPA on the blots was tested by the immunoenzymatic method with the use of horseradish peroxidase-conjugated rabbit antibodies against mouse Ig (Dakopatts, Copenhagen, Denmark), as described previously.'"
Reactions of the MoAhs with sy~tlwtic peptides ( Pepscan anuiysis). The epitope scanning kit was purchased from Cambridge Research Biochemicals (Northwich, UK). Peptides were synthesized on derivatized plastic pins, according to manufacturer's directions, as described by WaSniowska et al." All peptides, except those used for replacement analysis, were synthesized in duplicate or triplicate. To test the reactivity of the MoAbs with peptides, three octapeptides corresponding to the N-terminal amino acid sequence of GPA-M, GPA-N, and GPA-Mf were synthesized on the pins. The results of the binding assay were in good agreement with the results of agglutination and immunoblotting; those MoAbs that showed reaction with MF antigen in these two assays were bound to the three peptides (Fig 2) . Similar binding of the MoAbs to M-, N-, and Mgtypical sequences indicated the lack of blood group M specificity of the MoAbs in reaction with peptides. Further experiments were designed to find out which amino acid residues in the peptides were essential for the MoAbs binding.
RESULTS
Initial screening of the
Characterization of peptidic epitopes recognized by antiM/MR MoAhs. To locate the most active fragment(s) within GPA sequence, the set of peptides covering different fragments of the N-terminal portion of GPA-M and GPA-N was synthesized and tested (window analysis; see Fig 3) . The six overlapping octapeptides with the sequence of amino acids 1-8, 2-9, up to 6-13 of GPA-M or -N showed binding of the MoAbs, with a slight tendency to decrease gradually. It indicated that amino acid residues l-S of GPA have minor importance in the epitope. The critical residue was Met8, because its elimination abolished the binding of the antibodies (compare active peptides 2-8 and 3-8 with inactive 2-7;
see Fig 3) . Further amino acid residues (His9, seemed not to be important, perhaps except for some auxiliary role of His9 i n reaction with the MoAb E3.
More inl'orrnation was supplied by the replacement analysi?. The heptapeptide with the sequence of amino acid residues 2-8 of GPA-M was used as a parent structure, and each o f its amino acid residues was replaced with 19 other amino acid residues. The 140 new peptides were tested, and their binding activity was cornpared with the mean value of binding to the parent structure (7 pins) taken as 100%. The results shown in Fig 4 confirmed the importance of methionine (MetFi) residue that could be replaced only by tryptophan. The second essential amino acid residue was valine (Va16), because the MoAbs did not react or reacted weakly with most Val-replacement analogs. The tnost active of them was the peptide containing threonine in position of valine. The residues Ser2, Thr3, Thr4, and GlyS could be replaced by most other amino acids without loss of activity, and Ala7 showcd slightly lower replaccability than residues 2-5 but higher than MetX and Va16.
The results obtained with synthetic peptides showcd that the specificity of the three MoAbs tested is closely similar. They recognix ;I peptidic epitope in which the most important portion is the sequence Val-Ala-Met (amino acid residues 6-8 of GPA). The amino acid residues l-S of GPA JASKlEWlCZ ET AL polypeptide chain, which include blood group MN-related replacements at positions 1 and S , play no or a secondary role in reaction of nonglycosylated peptides with anti-M/Mg
MoAbs.
Reactions of anti-M/Mx MoAhs with de-O-Rl~co.c)luted e y f h m c~t e s .
The properties of "-reactive anti-M antibodies allowed us to conclude that these antibodies should react with de-0-glycosylated GPA independently of blood group type. To check this possibility, blood group M and N erythrocytes desialylatcd by neuraminidase were subscquently treated with 0-glycanase (releasing Gal-GnINAcresidues) and used in agglutination assay. The effectiveness of enzymc treatment was checked by SDS-PAGE of menbranes of treated KBC and by agglutination test with anti-T MoAb 22.19 directed against Gal-GalNAc-chams. The electrophoretic mobility of GPA after neuraminidase trcatrnent was slightly increased, and, after additional O-glycanasc treatment, CPA migrated much faster (Fig SA) . However, the anti-T MoAb 22.19, which did not agglutinate untreated erythrocytes, agglutinated neul-aminidase-treated and neuraminidasc/O-glycanse~treated erythrocytes with similar titer. These control experiments showed that de-0-glycosylation of GPA was significant (change of electrophoretic mobility of GPA) but not complete (agglutination by anti-T MoAb). For personal use only. on August 30, 2017. by guest www.bloodjournal.org From E3 are weakly reactive in asialo form."," It was shown by a weak agglutination of asialoM RBC by 425/2B, but the MoAb E3 used in our experiments was too weak to agglutinate asialo RBC (Fig SB) . As expected, all antibodies agglutinated O-glycanase-treated M and N KBC, albeit less strongly than untreated M and M'N RBC. The relatively weak agglutination of de-0-glycosylated RBC could be caused by (1) incomplete release of Gal-GalNAc-residues (shown by reaction with anti-T MoAb) and/or (2) decreased availability of deglyconylated blood group M and N determinants at the erythrocyte surface. It should be emphasixed that GPA in MF erythrocytes lacks oligosaccharide chains on amino acid residues 2-4 only, whereas 0-glycanase may have released 0-glycans in other portions of the GPA polypeptide chain that in turn may have changed the spatial arrangement of GPA molecules. Therefore, although the agglutination of O-glycanase-treated RBC was weaker than that of M' N RBC, the result was in favor of the conclusion that anti"/" MoAbs react with deglycosylated GPA independently of MN blood group type, a s was the case with their respective synthetic peptidcs. and S of GPA. It has been found that anti" and anti-N MoAbs show variations in subspecificity. They recognize glycopcptididc epitopes dependent on the 1st or 5th amino acid residue, dependent or not dependent on sialylation or on amino group, and their activity shows differences i n pHsialic acid-dependent epitopes require the presence of only one type of sialic acid residues, cu2.3Cal-linked or a2,hGalNAc-linked ones."
DISCUSSION
The anti-M/M MoAbs described in this report share some common properties. They are directed against cpitopec dependent on GlyS and on cr2,3Gal-linked sialic acid residues and independent of Serl and its amino group."-"-" The three closely similar anti-M/M? MoAbs showed only some quantitative differences in the degree of blood group specificity and dependence of epitopes on sialylation. One 01' them (E6) was highly specific for the sialylated blood group M-related epitope. Two other MoAbs (42Y2B and E3) were less specific. They reacted most strongly with sialylated blood group M antigen, but a distinctly weaker reaction with GPA-N and asialoGPA-M was detectable in some assays. Thc cpitopes for the anti"/"
MoAbs are resistant to periodatc oxidation/borohydridc reduction that converts sialic acid residues to shorter (7C or 8C) forms. Our rccent results" indicated that resistance of epitopes to periodate oxidation does not depend on the type ofsialic acid residues required but, rathcr. is correlated with internal position of the epitope in GPA polypeptide chain. Our data2' showed that not a l l anti" MoAbs specific for GlyS-related/periodate-resistant epitope are M?-reactive. However, all Mz"reactive anti" MoAb\ seem to recognize GlyS-dependent blood group M epitope, which is logical in view of the present finding that the epitope is also dependent on Val6 and Met8. The specificity of the anti-M/Mg MoAbs is different than the specificity of classical anti-MC antibodies found in humans, because the latter antibodies usually do not react with normal GPAs. Cartron et al" tested one human anti-" antibody with synthetic peptides and glycopeptides and found that its specificity was dependent on Leu1 (and not on Asn4) and on the lack of glycosylation of the epitope. The anti-M/ MS MoAbs react with the internal nonglycosylated peptidic epitope of GPA and, under some conditions (presence of GlyS). recognize this epitope in fully glycosylated (sialylated) GPA.
Modulation of antigenic properties by antigen glycosylation occurs in other glycoprotein antigens. even if carbohydrates do not participate directly in the Ag-Ab reaction. For example. 21 single glycosylation at a defined threonine residue in oncofetal fibronectin most probably induces conformational changes in the peptide to form the specific oncofetal epitope." Interestingly. this difference in glycosylation of oncofetal and adult normal tissue-derived fibronectin is caused by a subtle change in the substrate specificity of CYGalNAc transferase. The enzyme of fetal and cancer tissues may have broader specificity and is able to transfer GalNAc to that threonine residue that is not glycosylated by the enzyme of normal adult tissues." The opposite effect. ie. inactivation of a peptidic epitope by glycosylation. may be caused not only by steric hindrance but also by imposing alteration in peptide conformation or flexibility. The latter possibility was suggested by finding that masking of an epitope of the influenza virus hemagglutinin by N-glycosylation is independent of oligosaccharide size: the same effect is given by Asn-linked GlcNAc or larger oligosaccharide chains.'' On the other hand. earlier we found that a peptidic epitope of GPA (amino acid residues 39-43) is masked by sialic acid residues of adjacent 0-glycans that may be caused by ionic interaction of sialic acid with basic residues of the polypeptide chain." Further information suggesting the inducing of a specific peptide conformation by its glycosylation was supplied by eliciting specific T-cell responses for glycosylated peptides presented by major histocompatibility complex mole~ules.~"~" The experimental data in this field are still scarce. However. it has been suggested that the T-cell receptor does not react directly with carbohydrates. but the carbohydrate moiety may influence the binding of the core peptide to the major histocompatibility complex molecule to generate a complex with slightly different conformation than that formed with nonglycosylated peptides."
The case of anti-M/Mg MoAbs is unusual in that the effect of glycosylation is bidirectional. The VaWMet8-dependent epitope is recognized in sialylated GPA. provided that Gly. and not Glu. is present at position S. One of possible explanations of this specificity is that electrostatic repulsion between sialic acid and Glu residues makes the epitope sterically unaccessible for the antibodies. whereas the presence of GlyS residue allows its proper exposure. Desialylation of GPA (or release of sialic acid residues linked to Gal") probably changes the steric arrangement in that way that the epitope is not or is hardly recognized. Lack of the epitope accessibility in asialoGPA must be connected with widely understood masking effect of Gal-GalNAc-residues, because nonglycosylated peptide is again active. independent of which amino acid residue is present at position S. Similar properties showed MoAbs against leukosialin (CD43. poly-0-glycosylated glycoprotein) that recognized linear peptidic epitopes and reacted with nonglycosylated (recombinant) and native antigen, but not with desialylated leukosialin.'x In conclusion. these results indicate that sialylation of the oligosaccharide chain(s) may reverse the masking of peptidic epitope by asialochain. Therefore. loss of reactivity with the antibody resulting from antigen desialylation does not allow to predict that the antibody will not react with totally deglycosylated (eg, recombinant) antigen. 
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